Cancer Supportive Care Development Market Report: Overview of all products in therapeutic development for each indication

The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for cancer anorexia-cachexia syndrome, bone metastasis and cancer pain, and features dormant and discontinued projects.

Pune, India - March 1, 2018 /MarketersMedia/ —

The size of these pipelines ranges 24 products in cancer anorexia-cachexia syndrome to 52 in cancer pain. The majority of products in cancer anorexia-cachexia syndrome target the growth hormone secretagogue receptor type 1, although there are a range of other molecular targets in development. Within bone metastasis, the most common molecular targets are the tumor necrosis factor ligand superfamily member 11, and the hepatocyte growth factor receptor, along with a range of others. Finally, within cancer pain, neurotransmitters such as the mu type opioid receptor, and a range of ion channels, are the most common type of target, reflecting the pain treatment landscape in general.
Access Report Details at: https://www.themarketreports.com/report/cancer-supportive-care-drug-development-pipeline-review-2017
Reasons To Buy
• Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
• Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
• Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
• Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Get this report at: https://www.themarketreports.com/report/buy-now/935554
Scope
• Which companies are the most active within each pipeline?
• Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
• To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
• What are the most important R&D milestones and data publications to have happened in this disease area?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935554

Contact Info:
Name: Shirish Gupta
Email: [email protected]
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/cancer-supportive-care-development-market-report-overview-of-all-products-in-therapeutic-development-for-each-indication/307242

For more information, please visit https://www.themarketreports.com/report/cancer-supportive-care-drug-development-pipeline-review-2017

Source: MarketersMedia

Release ID: 307242